The present invention relates generally to therapeutics targeting the bacterium Porphyromonas gingivalis, including its proteases arginine gingipain A/B (Rgp), and their use for the treatment of disorders associated with P. gingivalis infection, including brain disorders such as Alzheimer's disease. In certain embodiments, the invention provides compounds according to Formula I and Formula III, as described herein, and pharmaceutically acceptable salts thereof.
本发明一般涉及治疗靶向细菌Porphyromonas gingivalis的治疗药物,包括其
蛋白酶精
氨酸龈
蛋白酶A/B(Rgp),以及它们用于治疗与P. gingivalis感染相关的疾病,包括脑部疾病如阿尔茨海默病。在某些实施例中,本发明提供根据本文所述的Formula I和Formula III的化合物,以及其药用可接受的盐。